Cambridge Investment Research Advisors’s Avadel Pharmaceuticals AVDL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-72,216	Closed	-$565K	–	3624
2025 Q1	$565K	Sell	72,216 -3,465	-5%	-$27.1K	﹤0.01%	2312
2024 Q4	$795K	Buy	+75,681	New	+$795K	﹤0.01%	2046
2024 Q1	–	Sell	-11,921	Closed	-$168K	–	3311
2023 Q4	$168K	Buy	+11,921	New	+$168K	﹤0.01%	2945